GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (HKSE:02196) » Definitions » 5-Year Dividend Growth Rate

Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) 5-Year Dividend Growth Rate : 6.70% (As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co 5-Year Dividend Growth Rate?

Shanghai Fosun Pharmaceutical (Group) Co's Dividends per Share for the three months ended in Dec. 2023 was HK$0.00.

During the past 12 months, Shanghai Fosun Pharmaceutical (Group) Co's average Dividends Per Share Growth Rate was -25.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 2.50% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 6.70% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Shanghai Fosun Pharmaceutical (Group) Co was 86.10% per year. The lowest was -27.20% per year. And the median was 14.30% per year.

Shanghai Fosun Pharmaceutical (Group) Co's Dividend Payout Ratio for the three months ended in Dec. 2023 was 0.00. As of today, Shanghai Fosun Pharmaceutical (Group) Co's Dividend Yield % is 3.75%.

Good Sign:

Shanghai Fosun Pharmaceutical (Group) Co Ltd stock dividend yield is close to 1-year high.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Shanghai Fosun Pharmaceutical (Group) Co's 5-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fosun Pharmaceutical (Group) Co's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Fosun Pharmaceutical (Group) Co's 5-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Fosun Pharmaceutical (Group) Co's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Shanghai Fosun Pharmaceutical (Group) Co's 5-Year Dividend Growth Rate falls into.



Shanghai Fosun Pharmaceutical (Group) Co 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Shanghai Fosun Pharmaceutical (Group) Co  (HKSE:02196) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Shanghai Fosun Pharmaceutical (Group) Co's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0/ 0.401
=0.00

During the past 13 years, the highest Dividend Payout Ratio of Shanghai Fosun Pharmaceutical (Group) Co was 0.56. The lowest was 0.34. And the median was 0.37.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Shanghai Fosun Pharmaceutical (Group) Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
HKD 0.4602023-07-312023-08-022023-08-24Cash DividendannuallyHKD:HKD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Shanghai Fosun Pharmaceutical (Group) Co's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=0.46/12.26
=3.75 %

Current Share Price is HK$12.26.
Shanghai Fosun Pharmaceutical (Group) Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is HK$0.46.

During the past 13 years, the highest Dividend Yield of Shanghai Fosun Pharmaceutical (Group) Co was 3.75%. The lowest was 0.46%. And the median was 1.16%.

Good Sign:

Shanghai Fosun Pharmaceutical (Group) Co Ltd stock dividend yield is close to 1-year high.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Fosun Pharmaceutical (Group) Co 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) Business Description

Traded in Other Exchanges
Address
No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233
Shanghai Fosun Pharmaceutical (Group) Co Ltd is a specialty and generic drug manufacturing company. Shanghai Fosun maintains five business segments, including Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. Most of the company's revenue is generated by its Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) Headlines

No Headlines